SCHEMBL10119944

SCHEMBL10119944

CC(c1nc2ccc(F)cn2c(=O)c1Br)N1C(=O)c2ccccc2C1O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 7/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
RAB9A P51151 4/20 0.32
PKM P14618 3/20 0.32
NPC1 O15118 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TP53 P04637 1/20 0.32
STAT3 P40763 1/20 0.32
STAT1 P42224 1/20 0.32
PIK3R1 P27986 1/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
FADS1 O60427 1/20 0.31
KCNA5 P22460 1/20 0.31
CYP11B1 P15538 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL890605 0.82 PIK3CD (0.37) PIK3CDTP53PIK3R1PIK3CBPIK3CG
SCHEMBL10119986 0.79 HTT (0.37) PIK3CDMEN1KMT2AATMRAB9A
SCHEMBL890505 0.77 PIK3CD (0.38) PIK3CDPIK3R1PIK3CBPIK3CGFADS1
SCHEMBL3097607 0.73 PIK3CD (0.37) PIK3CDPIK3R1PIK3CBPIK3CGFADS1
SCHEMBL10120340 0.72 PIK3CD (0.36) PIK3CDMEN1KMT2AATMRAB9A
SCHEMBL10120334 0.69 PIK3CD (0.47) PIK3CDCYP3A4CYP2D6CYP2C9
SCHEMBL19787854 0.68 DHODH (0.41) PIK3CDMEN1KMT2APIK3CBPIK3CG
SCHEMBL4471060 0.67 MEN1 (0.51) MEN1KMT2AATMRAB9APKM
SCHEMBL890589 0.66 HSP90AA1 (0.42) SMN1; SMN2TP53ALDH1A1HSD17B10
SCHEMBL19787858 0.66 PIK3CD (0.49) PIK3CDPIK3CBPIK3CGCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120083502-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120083502-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES MCL1, MALT1, BCL9 PIK3CD 24/4885MEN1 1146/4885KMT2A 679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.